
|Videos|June 7, 2023
Bispecific Antibodies in Development for the Treatment of R/R MM
Dr Jack Khouri highlights recent data updates on other BCMA-targeting bispecific antibodies that are in clinical development in multiple myeloma.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Afami-cel in Metastatic Synovial Sarcoma
2
How Are Key Lymphoma Data From ASCO and EHA 2026 Shaping Treatment?
3
Current Treatment Landscape of HER2-Positive Metastatic Breast Cancer and Phase 3 Trial Overview
4
Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC
5


















































































